[Therapy of polymyalgia rheumatica].
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000367:Age Factors; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000008:administration & dosage / Q000494:pharmacology; D001581:Benzothiadiazines; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D004232:Diuretics; D004334:Drug Administration Schedule; D004357:Drug Synergism; D013700:Giant Cell Arteritis / Q000188:drug therapy; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced; D011111:Polymyalgia Rheumatica / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D001569:Benzodiazepines; D003622:Dapsone; D011241:Prednisone
La terapia della polimialgia reumatica.